Eric Lewis
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Multiple Myeloma Research and Treatments 8
-
- Statistical Methods in Clinical Trials 4
- Co-authors
- David Rampe (2 shared papers)Michael K. Murawsky (1 shared paper)Daren J. Austin (1 shared paper)Amit Bar‐Or (1 shared paper)Sarah T. Kavanagh (1 shared paper)Per Soelberg Sørensen (1 shared paper)Susan A. VanMeter (1 shared paper)Richard A. Grove (1 shared paper)
- Journals
- Biopharmaceutics & Drug Disposition (2 papers)Blood (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Cancer (2 papers)Journal of Clinical Immunology (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Eric Lewis
31 papers receiving 1.5k citations
Eric Lewis's Hit Papers
Peers
Comparison fields: 5 of 99
- Hematology 669
- Oncology 542
- Radiology, Nuclear Medicine and Imaging 211
- Pathology and Forensic Medicine 150
- Immunology 182
Countries citing papers authored by Eric Lewis
This map shows the geographic impact of Eric Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Lewis more than expected).
Fields of papers citing papers by Eric Lewis
This network shows the impact of papers produced by Eric Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Lewis. The network helps show where Eric Lewis may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Lewis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study Hit paper breakdown → | 2019 | 637 |
| 2 | 2018 | 171 | |
| 3 | 1998 | 155 | |
| 4 | 2021 | 122 | |
| 5 | Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma Hit paper breakdown → | 2024 | 102 |
| 6 | 2023 | 52 | |
| 7 | 1997 | 43 | |
| 8 | 1994 | 41 | |
| 9 | 2011 | 32 | |
| 10 | 2014 | 30 | |
| 11 | 2012 | 26 | |
| 12 | 1991 | 23 | |
| 13 | 1986 | 22 | |
| 14 | 1992 | 22 | |
| 15 | 1992 | 21 | |
| 16 | 1995 | 15 | |
| 17 | 2019 | 10 | |
| 18 | 2022 | 10 | |
| 19 | 1984 | 9 | |
| 20 | 2007 | 6 |
About Eric Lewis
Eric Lewis is a scholar working on Hematology, Statistics and Probability, Immunology, Pharmacology and Infectious Diseases, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Statistical Methods in Clinical Trials (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Biosimilars and Bioanalytical Methods (3 papers), HIV/AIDS drug development and treatment (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Ion channel regulation and function (2 papers). The work is most often cited by research in Hematology (669 citations), Oncology (542 citations), Radiology, Nuclear Medicine and Imaging (211 citations), Pathology and Forensic Medicine (150 citations) and Immunology (182 citations). Eric Lewis has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David Rampe, Michael K. Murawsky, Daren J. Austin, Amit Bar‐Or, Sarah T. Kavanagh, Per Soelberg Sørensen, Susan A. VanMeter, Richard A. Grove, Jerry M. Tolson and Frederick J. Derosier. Their work appears in journals such as Biopharmaceutics & Drug Disposition, Blood, Antimicrobial Agents and Chemotherapy, Cancer and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.